LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 152 filers reported holding LOXO ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $77,624,000 | -6.6% | 554,177 | +13.9% | 0.14% | +12.2% |
| Q3 2018 | $83,099,000 | -18.9% | 486,440 | -17.7% | 0.12% | -20.6% |
| Q2 2018 | $102,481,000 | +3971.6% | 590,734 | +2061.6% | 0.16% | +2114.3% |
| Q3 2017 | $2,517,000 | -31.9% | 27,328 | -40.7% | 0.01% | -36.4% |
| Q2 2017 | $3,698,000 | +90.6% | 46,114 | 0.0% | 0.01% | +120.0% |
| Q1 2017 | $1,940,000 | – | 46,114 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |